ES2053632T3 - Piridiletanolaminas substituidas, procedimientos para su fabricacion y su utilizacion como promotores de la produccion en animales. - Google Patents

Piridiletanolaminas substituidas, procedimientos para su fabricacion y su utilizacion como promotores de la produccion en animales.

Info

Publication number
ES2053632T3
ES2053632T3 ES88111504T ES88111504T ES2053632T3 ES 2053632 T3 ES2053632 T3 ES 2053632T3 ES 88111504 T ES88111504 T ES 88111504T ES 88111504 T ES88111504 T ES 88111504T ES 2053632 T3 ES2053632 T3 ES 2053632T3
Authority
ES
Spain
Prior art keywords
alkyl
optionally substituted
represent
piridylethanolamines
promoters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88111504T
Other languages
English (en)
Inventor
Hans Dr Lindel
Werner Dr Hallenbach
Friedrich Prof Dr Berschauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2053632T3 publication Critical patent/ES2053632T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)

Abstract

LA INVENCION AQUI DESCRITA CONCIERNE PIRIDILETANOLAMINA DE LA FORMULA(I) DONDE R1 REPRESENTA CN, -COOR8, -CONR9R10 R2 REPRESENTA EVENTUALMENTE ALCILO SUSTITUIDO R3 REPRESENTA HIDROGENO, ALCILO O ALCENILO R4 REPRESENTA HIDROGENO, EVENTUALMENTE ALCILO O ALCENILO SUSTITUIDO R3 Y R4 JUNTOS CON EL ATOMO DE AZOE, AL CUAL ESTAN UNIDOS, REPRESENTAN UN EVENTUAL RESTO HETEROCICLICO SUSTITUIDO R5 REPRESENTA OH, ACILOXI O ALCOXI R6 REPRESENTA HIDROGENO O ALCILO R7 REPRESENTA HIDROGENO, ALCILO, CICLOALCILO, ALCILO SUSTITUIDO, EVENTUALMENTE ARALCILO SUSTITUIDO, ARILO O HETEROCICLILO R6 Y R7 PUEDEN REPRESENTAR, JUNTOS CON EL ATOMO DE AZOE ,AL CUAL ESTAN UNIDOS, UN EVENTUAL RESTO HETEROCICLICO SUSTITUIDO R8 REPRESENTA ALCILO R9 Y R10 REPRESENTAN, INDEPENDIENTES UNO DEL OTRO HIDROGENO, ALCIL, ALCENIL O JUNTOS CON EL ATOMO DE AZOE AL CUAL ESTAN UNIDOS UN EVENTUAL RESTO HETEROCICLICO SUSTITUIDO METODO PARA SU FABRICACION ASI COMO PRODUCTOS INTERMEDIOS PARA LA EXECUCION DE ESE METODO. LAS PIRIDILETANOLAMINASSIRVEN DE ESTIMULANTES DE RENDIMIENTO PARA LOS ANIMALES.
ES88111504T 1987-07-29 1988-07-18 Piridiletanolaminas substituidas, procedimientos para su fabricacion y su utilizacion como promotores de la produccion en animales. Expired - Lifetime ES2053632T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873725084 DE3725084A1 (de) 1987-07-29 1987-07-29 Substituierte pyridinethanolamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren

Publications (1)

Publication Number Publication Date
ES2053632T3 true ES2053632T3 (es) 1994-08-01

Family

ID=6332599

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88111504T Expired - Lifetime ES2053632T3 (es) 1987-07-29 1988-07-18 Piridiletanolaminas substituidas, procedimientos para su fabricacion y su utilizacion como promotores de la produccion en animales.

Country Status (16)

Country Link
US (1) US4920136A (es)
EP (1) EP0301348B1 (es)
JP (1) JPS6442468A (es)
KR (1) KR890002012A (es)
AT (1) ATE85327T1 (es)
AU (1) AU623339B2 (es)
DD (1) DD285350A5 (es)
DE (2) DE3725084A1 (es)
DK (1) DK422688A (es)
ES (1) ES2053632T3 (es)
GR (1) GR3007061T3 (es)
HU (1) HU202841B (es)
IL (1) IL87223A0 (es)
NZ (1) NZ225554A (es)
PL (1) PL153869B1 (es)
ZA (1) ZA885518B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651447B1 (fr) * 1989-09-01 1994-02-11 Atochem Nouveaux catalyseurs de fluoration en phase liquide.
DE4006794A1 (de) * 1990-03-03 1991-09-05 Bayer Ag Verfahren zur herstellung von aminoethanolderivaten
JP2001302639A (ja) * 2000-04-28 2001-10-31 Nippon Fine Chem Co Ltd アミノシアノピリジンの製造方法
KR200458143Y1 (ko) * 2011-10-04 2012-01-20 김진희 속눈썹 건조장치
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3175580D1 (en) * 1980-08-25 1987-01-02 American Cyanamid Co Method for enhancing the growth rate of meat-producing animals and for improving the lean meat to fat ratio thereof
NZ212204A (en) * 1984-06-04 1988-07-28 Merck & Co Inc Growth-promoting compositions containing hydroxylic compounds
DE3525336A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Arylethanolhydroxylamine, verfahren zu ihrer herstellung und ihre verwendung zur leistungsfoerderung
EP0225600A2 (de) * 1985-12-11 1987-06-16 Bayer Ag Verfahren zur Leistungsförderung bei Nutztieren, neue Aminophenylethylamin-Derivate und ihre Herstellung
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HU202841B (en) 1991-04-29
ATE85327T1 (de) 1993-02-15
AU623339B2 (en) 1992-05-14
KR890002012A (ko) 1989-04-07
ZA885518B (en) 1989-04-26
JPS6442468A (en) 1989-02-14
EP0301348B1 (de) 1993-02-03
US4920136A (en) 1990-04-24
EP0301348A2 (de) 1989-02-01
PL273962A1 (en) 1989-07-24
DE3878074D1 (de) 1993-03-18
PL153869B1 (en) 1991-06-28
DE3725084A1 (de) 1989-02-09
DK422688D0 (da) 1988-07-28
DD285350A5 (de) 1990-12-12
AU2021988A (en) 1990-02-01
GR3007061T3 (es) 1993-07-30
EP0301348A3 (en) 1989-04-19
NZ225554A (en) 1990-04-26
DK422688A (da) 1989-01-30
IL87223A0 (en) 1988-12-30
HUT49122A (en) 1989-08-28

Similar Documents

Publication Publication Date Title
ES2078291T3 (es) Nuevos derivados de acido a-nor-esteroide-3-carboxilico.
ATE137238T1 (de) Beta-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
ES2053632T3 (es) Piridiletanolaminas substituidas, procedimientos para su fabricacion y su utilizacion como promotores de la produccion en animales.
SE7902598L (sv) Cephalosporinanaloger
DK471979A (da) Estere af 1,1,2-triphenylalkenderivater
SE8700555D0 (sv) Purine derivatives, their production and medicaments containing them
IT1092721B (it) Procedimento per la coltura di microrganismi
PT82536A (de) Verfahren zur herstellung von 17alpha-ethinyl-17 beta-hydroxy-18-methyl-4,15-estradien-3-on und die neuen ausgangsverbindungenfur dieses verfahren
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
DE69109953T2 (de) Alfa-fluorocarbonsäurederivate als Zwischenprodukte zur Herstellung von Fungiziden.
DE69521281T2 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
DE69012845D1 (de) Exo-3'-4'-O-benzyliden-3"-demethylchartreusin und seine Salze.
ES2089281T3 (es) Nuevos derivados de 2-mercaptometileno-tetrahidronaftaleno y 2-carboxamida indanos como inhibidores de la encefalinasa.
DD137807A3 (de) Anlage zur kultivierung von mikroorganismen
IT7850955A0 (it) Procedimento per la coltura aerobica di microorganismi
DE69120529T2 (de) Unterstützende verwendung von linomide (r)
SU651022A1 (ru) Способ непрерывного культивировани микроорганизмов
IT1088592B (it) Procedimento per la coltura di microorganismi
DD133804A1 (de) Verfahren zur herstellung von suspensionspolymerisaten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301348

Country of ref document: ES